comparemela.com

Page 5 - Aprilw Armstrong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Asian Patients With Psoriasis Have Shortest Visits, Study Shows

Dermatologists spent less time with Asian patients with psoriasis than patients of other races and ethnicities, the study investigators reported.

United statesTufts medical centerDeboraha scottLos angelesClarissa yangKevink wuAprilw armstrongNational ambulatory medical care surveyHarvard medical schoolUniversity of southern californiaHealth statisticsPrevention national centerHispanic blackHispanic whiteSouthern californiaDisease control

Dermavant Sciences: Dermavant to Present New Data from Phase 3 Trial Program of VTAMA (tapinarof) cream, 1% for Adults with Plaque Psoriasis at the 2022 EADV Congress

- Two posters will highlight clinical data for VTAMA cream on treat-to-target outcomes and quality of life measures - Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing

United statesKima pappChristopherem griffithsLaurence wattsAnnam tallmanRobert bissonnetteAngela salerno robinPhilipm brownKostenloser wertpapierhandelMarkg lebwohlAprilw armstrongEuropean academy of dermatologyDrug administrationDermavant sciences gmbRoivant sciencesDermavant sciences inc

Asian Psoriasis Patients Get Less Time With Dermatologists, Study Suggests

Cross-sectional study shows Asian patients have shortest face-to-face visits

New yorkUnited statesLos angelesKevink wuAprilw armstrongKeck school of medicineUniversity of southern californiaNational ambulatory medical careKeck schoolSouthern californiaNational ambulatory medical care survey

Dermavant Sciences: Dermavant Showcases New Long-Term Durability and Tolerability Data from Phase 3 PSOARING 3 Trial of Tapinarof Cream for Adults with Plaque Psoriasis at the 2022 AAD Annual Meeting

- Tapinarof demonstrated continued improvements for up to 52 weeks in efficacy outcomes, quality of life measures, and tolerability scores with no associated tachyphylaxis - Tapinarof was well-tolerated

United statesLaurence wattsKostenloser wertpapierhandelAprilw armstrongAngela salerno robinPhilipm brownProgram for tapinarofDrug administrationKeck school of medicineDean for clinical research in dermatologyAmerican academy of dermatologyRoivant sciencesDermavant sciencesLinkedin dermavant sciencesAnnual meetingKeck medicine

Dermavant Sciences: Dermavant to Present New Data from the Phase 3 PSOARING 3 Long-Term Extension Trial of Tapinarof Cream for Adults with Plaque Psoriasis at the 2022 American Academy of Dermatology Annual Meeting

- Two posters will present data across secondary efficacy outcomes, quality of life and tolerability scores of tapinarof cream 1% once daily - Dermavant Sciences, a clinical-stage biopharmaceutical

United statesLaurence wattsMelinda gooderhamAnnam tallmanAngela salerno robinPhilipm brownLaurak ferrisKostenloser wertpapierhandelAprilw armstrongBenjamin ehstDavids rubensteinSeemalr desaiProgram for tapinarofExhibition centerDrug administrationAmerican academy of dermatology

vimarsana © 2020. All Rights Reserved.